Encompass Health Inc. (EHC): Gedhene kewajiban jangka dawa

Encompass (EHC) - logo korporat

Encompass Health (EHC) long-term debt demonstrates leverage dynamics, with the latest value recorded as 2.80. Strict government licensing quotas for clinics serve as a moat for the leader. Growth is driven by an aging population, favorable Medicare rates, and network expansion. Staff retention ensures a sustainable workload, preventing burnout among nurses and physical therapists.

EHC Encompass Health Inc.: Utang jangka dawa perusahaan ing interval 04.07.2022 - 28.10.2026
Produk seri Encompass Health Corp

Encompass Health long-term debt reflects a strategy of long-term financing for capital expenditures. This metric aggregates all credit obligations with maturities exceeding one year, which is clearly demonstrated by the price action of the corporation's long-term loans and borrowings. The growth of this metric is driven by the expansion of the hospital network to serve the aging US population. Analyzing the borrowing vector allows for an assessment of the balance between the debt load and the pace of infrastructure expansion.

Analisis pesaing

HCA - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Tenet Healthcare Corporation THC|FMS: Gedhene kewajiban jangka dawa|SOLV (Solventum Inc.) - Utang jangka dawa perusahaan|Universal Health Services, Inc. (UHS) - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan DVA (DaVita Inc.)|Utang jangka dawa RDNT|Utang jangka dawa perusahaan Option Care Health, Inc. OPCH|Tanggungan utang jangka dawa perusahaan Surgery Partners Inc SGRY|Kewajiban jangka dawa perusahaan Premier Corp (PINC)|Gedhene kewajiban jangka dawa America's Best Contacts & Eyeglasses EYE|PGNY (Progyny, Inc.) - Utang jangka dawa perusahaan|ARDT: Utang jangka dawa|Utang jangka dawa perusahaan Select Medical Holdings|Astrana Health Inc (ASTH) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan MD|Kewajiban jangka dawa perusahaan USPH|The Pennant Group, Inc. - Utang jangka dawa perusahaan|Utang jangka dawa ORGO (organogenesis.com)|Nutex Health - Utang jangka dawa perusahaan|Auna S.A. - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan SBC Medical Group Inc|EOLS - Kewajiban jangka dawa|CYH: Utang jangka dawa perusahaan|SKIN (BeautyHealth) - Utang jangka dawa perusahaan|MDWD: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa BTMD|JYNT (The Joint Corporation) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa DocGo, Inc DCGO|Kewajiban jangka dawa perusahaan P3 Health Partners|Silihan lan utang jangka dawa perusahaan Gain Therapeutics Inc. GANX|Utang jangka dawa perusahaan EUDA Health (EUDA)|BMGL - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan CLGN|Cuprina Holdings Limited (CUPR) - Utang jangka dawa|CCM (Concord Medical Services) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan AMS|Utang jangka dawa perusahaan MEDIROM Healthcare Group (MRM)|Utang jangka dawa perusahaan avalon-globocare.com ALBT|Kewajiban jangka dawa perusahaan DIH Holding US Inc. (DHAI)|Gedhene kewajiban jangka dawa Carmell Corp XAGE|Utang jangka dawa perusahaan NewGenIvf Group Limited (NIVF)|ATIP - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan CMAX|Kindly MD Inc (KDLY) - Utang jangka dawa|MODV - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan Novo Integrated Sciences Corp|Utang jangka dawa perusahaan SSY (SunLink Health Systems)|Kewajiban jangka dawa perusahaan imacholdings.comm BACK